🇺🇸 FDA
Pipeline program

Conventional medical treatment

CMMo/OCC/2012

Phase 3 small_molecule completed

Quick answer

Conventional medical treatment for Coronary Atherosclerosis and Other Heart Disease is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Coronary Atherosclerosis and Other Heart Disease
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials